Results 1 to 10 of about 40,707 (252)
Incidence and predictors of pulmonary aspergillosis in patients with lung cancer: a systematic review and meta-analysis [PDF]
Frontiers in MedicineBackgroundPulmonary aspergillosis is a rare but serious complication following lung cancer surgery, increasing the risk of mortality. The incidence of pulmonary aspergillosis and its risk factors among lung cancer patients is unknown.
Geling Teng +3 more
doaj +2 more sources
Pulmonary aspergillosis: diagnosis and treatment
European Respiratory Review, 2022 Aspergillus species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) and chronic pulmonary aspergillosis (CPA).
Frederic Lamoth, Thierry Calandra
doaj +4 more sources
Observational study of the recent efficacy and economy of itraconazole vs. voriconazole in perioperative pulmonary aspergillosis [PDF]
Frontiers in SurgeryBackgroundAntifungal therapy is a common treatment option for pulmonary aspergillosis, but its use to prevent recurrence and relieve symptoms in patients with pulmonary aspergillosis remains controversial.
Peng Chen +7 more
doaj +2 more sources
Chronic forms of pulmonary aspergillosis [PDF]
Clinical Microbiology and Infection, 2001 Aspergillus is a genus of fungi commonly found in all environments. Remarkably, only a few species cause disease and equally remarkably, those same species cause multiple diseases. In the lung, exposure to the fungus, the immunological status of the individual and the condition of the lung determine the pattern of disease.
David W. Denning
openaire +4 more sources
Surgery for pulmonary aspergillosis
The Journal of Thoracic and Cardiovascular Surgery, 1969 Karl P. Klassen +3 more
openaire +4 more sources
Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]
Current Medical Mycology, 2022 Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed +7 more
doaj +1 more source
Obstructive Tracheobronchitis in Influenza-Associated Pulmonary Aspergillosis [PDF]
DiagnosticsWe report a bronchoscopic image of a 36-year-old with significant airway obstruction from obstructive tracheobronchitis secondary to invasive pulmonary aspergillosis. It is rare to see such a severe form of obstructive tracheobronchitis, likely caused by
Shuyi Zhang +3 more
doaj +2 more sources
Frontiers in Cellular and Infection Microbiology, 2022 This study aimed to obtain further in-depth information on the value of metagenomic next-generation sequencing (mNGS) for diagnosing pulmonary aspergillosis in non-neutropenic patients.
Shujun Bao +4 more
doaj +1 more source
Seminars in Respiratory and Critical Care Medicine, 2008 As the population of patients with prolonged neutropenia, those receiving hematopoietic stem cell transplantation or lung transplantation, or those with human immunodeficiency virus or acquired immunodeficiency syndrome continues to increase, the rising incidence of pulmonary aspergillosis is unlikely to diminish.
George R, Thompson, Thomas F, Patterson
openaire +2 more sources
Chronic pulmonary aspergillosis - case series and review of Indian literature
Indian Journal of Respiratory Care, 2021 Aspergillus species, especially Aspergillus fumigatus, can cause varied pulmonary manifestations depending on the host immune status and duration of infection. Chronic pulmonary aspergillosis (CPA) is an under-reported entity, and its diagnosis remains a
Vikas Marwah +6 more
doaj +1 more source